BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 16 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -38.1% | 18,400 | +0.5% | 0.00% | – |
| Q2 2022 | $21,000 | -91.9% | 18,300 | -79.7% | 0.00% | – |
| Q2 2021 | $259,000 | -78.8% | 90,102 | +67.5% | 0.00% | -100.0% |
| Q2 2020 | $1,224,000 | +650.9% | 53,800 | +153.8% | 0.00% | – |
| Q1 2020 | $163,000 | +22.6% | 21,200 | +48.3% | 0.00% | – |
| Q4 2019 | $133,000 | +141.8% | 14,300 | +40.2% | 0.00% | – |
| Q2 2018 | $55,000 | 0.0% | 10,200 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -72.5% | 10,200 | -72.7% | 0.00% | – |
| Q4 2017 | $200,000 | +4.2% | 37,300 | +38.7% | 0.00% | – |
| Q3 2017 | $192,000 | – | 26,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |